Industry: Medical Region: European Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A European innovative medical device company is committed to developing a global treatment solution for chronic venous insufficiency (CVI). Its core product, the "empty vein ablation" minimally invasive interventional catheter, effectively solves the industrial problems of limited effect and insufficient safety of existing therapies in treating large veins through non-thermal and non-swelling outpatient surgery.
At present, the technology has been authorized by 18 patents, and another 7 patents are pending. The clinical verification and one-year follow-up study have been completed, and the products have obtained CE certification and are qualified to enter the EU market.
Cooperation mode:
Enterprises are now seeking financing and technical cooperation.